Your session is about to expire
← Back to Search
Brain-Computer Interface
Brain-Computer Interface for ALS (CONVOY Trial)
N/A
Waitlist Available
Research Sponsored by Neuralink Corp
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether participants from a previous study can use an implant to control devices like a robotic arm with their brain activity. The goal is to see if this method is effective, consistent, and
Who is the study for?
This trial is for individuals with severe mobility impairments due to conditions like quadriplegia, spinal cord injury, or ALS. Participants should have previously been part of the PRIME Study and are now looking to test controlling assistive devices using their brain activity.
What is being tested?
The CONVOY Study tests if participants can use the N1 Implant from a prior study to control an Assistive Robotic Arm (ARA) and other devices by modulating brain activity. It aims to evaluate how effective, consistent, and safe this neural control is.
What are the potential side effects?
While specific side effects aren't listed here, potential risks may include discomfort at the implant site, headaches from concentration required for device control, or fatigue due to mental exertion.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: SingleExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Neuralink CorpLead Sponsor
2 Previous Clinical Trials
11 Total Patients Enrolled
2 Trials studying Quadriplegia
11 Patients Enrolled for Quadriplegia